We are live on ! Find out more
CLDX icon

Celldex Therapeutics

185 hedge funds and large institutions have $2B invested in Celldex Therapeutics in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 59 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $2.29M | Put options by funds: $750K

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

9% more capital invested

Capital invested by funds: $1.83B → $2B (+$169M)

3.7% more ownership

Funds ownership: 106.51%110.21% (+3.7%)

1% more funds holding

Funds holding: 184185 (+1)

2% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 59

Holders
185
Holders Change
+1
Holders Change %
+0.54%
% of All Funds
2.25%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
25
Increased
58
Reduced
59
Closed
22
Calls
$2.29M
Puts
$750K
Net Calls
+$1.53M
Net Calls Change
+$4.97M
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
201
Simplex Trading
Illinois
-$29K -1,136 Closed
ACM
202
Aster Capital Management
United Arab Emirates
-$26.2K -1,014 Closed
HHGA
203
Halbert Hargrove Global Advisors
California
-$2.02K -78 Closed
C
204
Covestor
United Kingdom
-$53 -2 -20%